D-0924-2019 Class I Terminated

Recalled by King Bio Inc. — Asheville, NC

FDA drug recall D-0924-2019 was initiated by King Bio Inc. on Jul 20, 2018 and is designated Class I. Reason for recall: Microbial contamination The recall status is terminated (terminated Jan 19, 2022). Affected quantity: 3800 bottles.

Recall Details

Product Type
Drugs
Report Date
Mar 20, 2019
Initiation Date
Jul 20, 2018
Termination Date
Jan 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3800 bottles

Product Description

NET Remedies #8 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia

Reason for Recall

Microbial contamination

Distribution Pattern

U.S.A. Nationwide, Canada, and Australia.

Code Information

Lots: AUS-011117F Exp. 01/20; AUS-011916G Exp. 01/19; AUS-030816H Exp. 03/19; AUS-030917B Exp. 03/20; AUS-050516G Exp. 05/19; AUS-082616A Exp. 08/19; AUS-091515G Exp. 09/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0924-2019
openFDA file date
Oct 6, 2026
Loaded by RegDataLab
Oct 12, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it. FDA may have changed the recall since.